Loperamide, an FDA-Approved antidiarrhea drug, effectively reverses the resistance of multidrug resistant MCF-7/MDR1 human breast cancer cells to doxorubicin-induced cytotoxicity

Yanfei Zhou, Rajagopalan Sridhar, Liang Shan, Wei Sha, Xinbin Gu, Saraswati Sukumar

Research output: Contribution to journal › Article › peer-review

15 Scopus citations

Fingerprint

Dive into the research topics of 'Loperamide, an FDA-Approved antidiarrhea drug, effectively reverses the resistance of multidrug resistant MCF-7/MDR1 human breast cancer cells to doxorubicin-induced cytotoxicity'. Together they form a unique fingerprint.

Medicine & Life Sciences